Earnings
Curiositystream Outperforms Consensus Estimates With Q4 Earnings Beat
Curiositystream reported quarterly results that surpassed analyst expectations on both top and bottom lines.
OPTIMIZERx Beats Earnings and Revenue Estimates in Latest Quarter
OPTIMIZERx reported quarterly results that surpassed Wall Street expectations for both earnings per share and overall revenue.
Allogene Therapeutics Reports Fourth-Quarter Earnings and Revenue Beat
Allogene Therapeutics reported fourth-quarter results that surpassed Wall Street estimates for both earnings and revenue.
Stem Reports Fourth-Quarter Earnings Beat Alongside Revenue Miss
Stem reported fourth-quarter financial results, topping per-share earnings estimates by $0.21 while missing top-line revenue expectations.
Fossil Q4 Earnings and Revenue Beat Wall Street Estimates
Fossil Group reported quarterly results that surpassed analyst expectations for both earnings and revenue.
Leslie's Reports Earnings and Revenue Miss for the Quarter
Leslie's missed Wall Street earnings estimates by $1.10 per share alongside a shortfall in quarterly revenue.
Virgin Galactic Q4 Earnings Beat Estimates Despite Revenue Shortfall
Virgin Galactic Holdings reported a quarterly earnings per share beat of $0.15, though revenue missed consensus expectations.
Usio Tops Estimates with Higher Revenue and Earnings Beat
Usio reported quarterly financial results that exceeded consensus estimates for both earnings and revenue.
Perma-Fix Inc Misses Fourth-Quarter Estimates on Earnings and Revenue
Perma-Fix Inc reported financial results that fell short of analyst expectations, missing earnings estimates by $0.15 alongside a revenue miss.
EnerSys Beats Earnings and Revenue Estimates
EnerSys reported financial results that exceeded consensus estimates for both earnings per share and overall revenue.
Harmonic Reports Earnings and Revenue Beat
Harmonic posted financial results that surpassed analyst expectations for both earnings and revenue.
Atara Biotherapeutics Misses Q4 Estimates on Earnings and Revenue
Atara Biotherapeutics Inc. reported quarterly results that fell short of Wall Street estimates for both earnings and revenue.
Cisco Forecasts Strong Fiscal 2027 Driven by AI-Led Networking Demand
Cisco Systems projected a strong fiscal 2027, pointing to surging networking demand powered by the artificial intelligence boom.
Omeros Shares Surge 13% Following Strong Earnings and Revenue Beat
Omeros Corporation shares jumped 13% after the company reported stronger-than-expected earnings and revenue figures.
Red Robin Gourmet Burgers Posts Earnings and Revenue Beat
Red Robin Gourmet Burgers reported quarterly results that surpassed analyst expectations on both top and bottom lines.
Jack In The Box Reports Q4 Earnings Beat Despite Revenue Miss
Jack In The Box posted fourth-quarter earnings that surpassed Wall Street expectations by $0.06, though revenue fell short of consensus estimates.
Resideo Technologies Surpasses Earnings and Revenue Estimates
Resideo Technologies reported quarterly results that beat analyst expectations for both earnings per share and total revenue.
Alpha & Omega Semiconductor Tops Q4 Estimates on Earnings and Revenue
Alpha & Omega Semiconductor reported quarterly results that exceeded analyst expectations for both earnings and revenue.
Kimball Electronics Misses Q4 Estimates on Earnings and Revenue
Kimball Electronics reported a lower-than-expected quarterly performance, missing both earnings and revenue consensus estimates.
Omeros Posts Better-Than-Expected Quarterly Earnings and Revenue
Omeros Corporation surpassed Wall Street consensus estimates for both earnings and revenue during the quarter.
Coherent and Cisco Prepare to Release Earnings After the Bell
Investors await quarterly financial results from Coherent and Cisco Systems following the market close.
TeraGo Q2 2026 Presentation Highlights Profitability Gains Amid Revenue Pressures
TeraGo released its second-quarter 2026 presentation slides, detailing margin and profitability improvements alongside ongoing top-line revenue headwinds.
McGraw Hill Reports 77% Recurring Revenue and Margin Expansion in Q1 FY27
McGraw Hill released its first-quarter fiscal 2027 presentation slides, highlighting recurring revenue reaching 77% alongside expanding profit margins.
Ascendis Pharma Q2 2026 earnings exceed estimates on launch momentum
Danish biotech firm posts quarterly revenue above market forecasts as new product launches drive growth. Earnings call highlights pipeline progress.